SCHEMBL14600552

SCHEMBL14600552

CC(C)OP(=O)(CN)Oc1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ANPEP P15144 2/20 0.46
LAP3 P28838 2/20 0.46
L3MBTL1 Q9Y468 3/20 0.46
ALDH1A1 P00352 1/20 0.46
CA12 O43570 1/20 0.44
CA1 P00915 1/20 0.44
CA2 P00918 1/20 0.44
CA4 P22748 1/20 0.44
CA5A P35218 1/20 0.44
CA7 P43166 1/20 0.44
CA9 Q16790 1/20 0.44
CA5B Q9Y2D0 1/20 0.44
SRC P12931 1/20 0.41
KLK8 O60259 1/20 0.40
PLAU P00749 1/20 0.40
KLK2 P20151 1/20 0.40
KLK4 Q9Y5K2 1/20 0.40
TDP1 Q9NUW8 1/20 0.40
POLB P06746 1/20 0.40
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5945294 0.87 ANPEP (0.44) ANPEPLAP3L3MBTL1ALDH1A1CA12
SCHEMBL10626029 0.83 SRC (0.52) ANPEPLAP3L3MBTL1SRCKLK8
SCHEMBL5945293 0.81 CCNT1 (0.48) ANPEPLAP3L3MBTL1ALDH1A1CA12
Hydrochloric Acid SCHEMBL10623947 0.81 SRC (0.50) ANPEPLAP3L3MBTL1SRCKLK8
Bromide SCHEMBL10905594 0.81 SRC (0.50) ANPEPLAP3L3MBTL1SRCKLK8
SCHEMBL1028971 0.76 L3MBTL1 (0.53) ANPEPLAP3L3MBTL1ALDH1A1CA12
SCHEMBL2535071 0.76 L3MBTL1 (0.53) ANPEPLAP3L3MBTL1ALDH1A1CA12
SCHEMBL10739177 0.74 CTSA (0.43) L3MBTL1ALDH1A1POLB
SCHEMBL14269491 0.74 ANPEP (0.42) ANPEPLAP3L3MBTL1ALDH1A1CA12
SCHEMBL9485312 0.74 BTN3A1 (0.41) ANPEPLAP3L3MBTL1ALDH1A1CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070010489-A1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds GILEAD SCIENCES, INC. 2007-01-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070010489-A1 Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds PPA1, PNP, PPME1 ANPEP 24/4885LAP3 222/4885L3MBTL1 837/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.